Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
Journal of Lipid and Atherosclerosis ; : 195-204, 2020.
Artículo en Inglés | WPRIM | ID: wpr-786071

RESUMEN

OBJECTIVE: This study investigated whether serum bilirubin levels can predict the progression of carotid atherosclerosis in individuals with type 2 diabetes mellitus (T2DM).METHODS: This observational study included 1,381 subjects with T2DM in whom serial measurements of carotid intima-media thickness (CIMT) were made at 1- to 2-year intervals for 6–8 years. The progression of carotid atherosclerosis was defined as newly detected plaque lesions on repeat ultrasonography. After dividing total serum bilirubin levels into tertiles, the association between total serum bilirubin at baseline and plaque progression status was analyzed.RESULTS: Among 1,381 T2DM patients, 599 (43.4%) were categorized as having plaque progression in their carotid arteries. Those with plaque progression were significantly older; showed a higher prevalence of hypertension, abdominal obesity, and chronic kidney disease; and had a longer duration of T2DM, higher levels of total cholesterol (TC), triglycerides, and insulin resistance, and lower total bilirubin concentrations than those with no plaque progression. When total serum bilirubin levels were divided into tertiles, the highest tertile group was younger than the lowest tertile group, with higher levels of TC and high-density lipoprotein cholesterol. Multiple logistic regression analysis demonstrated that higher serum bilirubin levels were associated with a significantly lower risk of CIMT progression (odds ratio, 0.584; 95% confidence interval, 0.392–0.870; p=0.008). Age (p<0.001), body mass index (p=0.023), and TC (p=0.019) were also associated with the progression of carotid atherosclerosis in T2DM patients.CONCLUSION: Total serum bilirubin is independently associated with progression of atherosclerosis in the carotid arteries in T2DM patients.


Asunto(s)
Humanos , Aterosclerosis , Bilirrubina , Índice de Masa Corporal , Arterias Carótidas , Enfermedades de las Arterias Carótidas , Grosor Intima-Media Carotídeo , Colesterol , Diabetes Mellitus Tipo 2 , Hipertensión , Resistencia a la Insulina , Lipoproteínas , Modelos Logísticos , Obesidad Abdominal , Estudio Observacional , Prevalencia , Insuficiencia Renal Crónica , Triglicéridos , Ultrasonografía
2.
Journal of Korean Diabetes ; : 149-156, 2019.
Artículo en Coreano | WPRIM | ID: wpr-761490

RESUMEN

According to the American Diabetes Association (ADA) and the European Association for the Study of Diabetes guideline for treatment of diabetes, glucagon-like peptide-1 receptor agonist (GLP-1 RA) is recommended in diabetic patients with established atherosclerotic cardiovascular disease. This recommendation is based on the results of recent cardiovascular outcome trials of this kind of medications. GLP-1 RAs have a glucose lowering effect with weight loss and a lower incidence of hypoglycemia, and can improve cardiovascular outcomes such as three-point major cardiovascular events composed of death from cardiovascular causes, non-fatal myocardial infarction, and non-fatal stroke. Also, several GLP-1 RAs have beneficial effects on renal outcomes, mainly due to improvement in macroalbuminuria. In addition, high-dose liraglutide (3 mg/day subcutaneous injection) showed efficacy for reducing body weight. Therefore GLP-1 RA may be effective in patients with established cardiovascular disease, chronic kidney disease, and/or metabolic syndrome.


Asunto(s)
Humanos , Peso Corporal , Enfermedades Cardiovasculares , Diabetes Mellitus , Péptido 1 Similar al Glucagón , Receptor del Péptido 1 Similar al Glucagón , Glucosa , Hipoglucemia , Incidencia , Enfermedades Renales , Liraglutida , Infarto del Miocardio , Obesidad , Insuficiencia Renal Crónica , Accidente Cerebrovascular , Pérdida de Peso
3.
The Korean Journal of Critical Care Medicine ; : 134-139, 2016.
Artículo en Inglés | WPRIM | ID: wpr-770934

RESUMEN

In critically ill patients, disseminated intravascular coagulation (DIC) is a common and fatal hematological disorder. DIC is a physiological response to a variety of underlying stimuli that provoke generalized activation of the hemostatic mechanism and is common in septic patients and those with hematological or non-hematological malignant neoplasms. Bleeding is a common clinical feature, and diffuse or multiple-site mucocutaneous bleeding, such as petechia, ecchymosis and hemorrhage from gastrointestinal tract, is often seen. A 58-year-old male was recently diagnosed with intracranial hemorrhage (ICH) caused by DIC associated with sepsis. Mortality of ICH caused by DIC is very high because the underlying condition cannot be quickly treated. Awareness of the possibility of DIC developing in a critically ill patient and the need for immediate initiation of plasma or platelet replacement therapy are important. To the best of our knowledge, this is the first reported case of intracranial hemorrhage in a Korean patient with DIC associated with sepsis.


Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Plaquetas , Enfermedad Crítica , Dacarbazina , Coagulación Intravascular Diseminada , Equimosis , Tracto Gastrointestinal , Hemorragia , Hemorragias Intracraneales , Mortalidad , Plasma , Sepsis
4.
Korean Journal of Critical Care Medicine ; : 134-139, 2016.
Artículo en Inglés | WPRIM | ID: wpr-42558

RESUMEN

In critically ill patients, disseminated intravascular coagulation (DIC) is a common and fatal hematological disorder. DIC is a physiological response to a variety of underlying stimuli that provoke generalized activation of the hemostatic mechanism and is common in septic patients and those with hematological or non-hematological malignant neoplasms. Bleeding is a common clinical feature, and diffuse or multiple-site mucocutaneous bleeding, such as petechia, ecchymosis and hemorrhage from gastrointestinal tract, is often seen. A 58-year-old male was recently diagnosed with intracranial hemorrhage (ICH) caused by DIC associated with sepsis. Mortality of ICH caused by DIC is very high because the underlying condition cannot be quickly treated. Awareness of the possibility of DIC developing in a critically ill patient and the need for immediate initiation of plasma or platelet replacement therapy are important. To the best of our knowledge, this is the first reported case of intracranial hemorrhage in a Korean patient with DIC associated with sepsis.


Asunto(s)
Humanos , Masculino , Persona de Mediana Edad , Plaquetas , Enfermedad Crítica , Dacarbazina , Coagulación Intravascular Diseminada , Equimosis , Tracto Gastrointestinal , Hemorragia , Hemorragias Intracraneales , Mortalidad , Plasma , Sepsis
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA